Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125959641 | 12595964 | 1 | I | 201605 | 20160613 | 20160727 | 20160727 | PER | US-ASTRAZENECA-2016SE65535 | ASTRAZENECA | 989.00 | MON | F | Y | 77.10000 | KG | 20160727 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125959641 | 12595964 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | U | 21366 | 5 | MG | TABLET | TIW | ||||||
125959641 | 12595964 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 1 OR 2 CAPSULES AT NIGHT | 0 | CAPSULE | |||||||||
125959641 | 12595964 | 3 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 0 | 100 | MG | CAPSULE | TID | |||||||
125959641 | 12595964 | 4 | C | HYDROXYCHLOR | HYDROXYCHLOROQUINE | 1 | 0 | ||||||||||||
125959641 | 12595964 | 5 | C | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
125959641 | 12595964 | 6 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
125959641 | 12595964 | 7 | C | COQ10 | UBIDECARENONE | 1 | 0 | ||||||||||||
125959641 | 12595964 | 8 | C | BIO CURCUMIN | 2 | 0 | |||||||||||||
125959641 | 12595964 | 9 | C | MELOXICAM. | MELOXICAM | 1 | 0 | ||||||||||||
125959641 | 12595964 | 10 | C | FISH OIL | FISH OIL | 1 | 0 | ||||||||||||
125959641 | 12595964 | 11 | C | TYLENOL | ACETAMINOPHEN | 1 | 0 | ||||||||||||
125959641 | 12595964 | 12 | C | HYDROCO-APAP | 2 | 0 | |||||||||||||
125959641 | 12595964 | 13 | C | HYDROCO-APAP | 2 | 0 | |||||||||||||
125959641 | 12595964 | 14 | C | ALLERGY MEDICINE | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
125959641 | 12595964 | 15 | C | NEURONTIN | GABAPENTIN | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125959641 | 12595964 | 1 | Blood cholesterol increased |
125959641 | 12595964 | 2 | Fibromyalgia |
125959641 | 12595964 | 3 | Fibromyalgia |
125959641 | 12595964 | 4 | Systemic lupus erythematosus |
125959641 | 12595964 | 5 | Obsessive-compulsive disorder |
125959641 | 12595964 | 6 | Blood cholesterol increased |
125959641 | 12595964 | 7 | Homeopathy |
125959641 | 12595964 | 8 | Homeopathy |
125959641 | 12595964 | 9 | Antiinflammatory therapy |
125959641 | 12595964 | 10 | Homeopathy |
125959641 | 12595964 | 11 | Headache |
125959641 | 12595964 | 12 | Headache |
125959641 | 12595964 | 13 | Pain |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125959641 | 12595964 | Asthenia | |
125959641 | 12595964 | Fatigue | |
125959641 | 12595964 | Headache | |
125959641 | 12595964 | Malaise | |
125959641 | 12595964 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125959641 | 12595964 | 3 | 20151125 | 0 |